1Blasko J C,Grimm P d,Ashley R,etal.Palladium-103 brachytherapy for prostate carcinoma.IntJ Radiat Oncol Biol Phys,2000,46:839-850.
2Wu A,Zwicker D,Sternick E S.Tumor dose specification of I-125 seed implants.MedPhys,1985,12:27.
3Taplin M E,Bubley G J,Ko Y J,etal.Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.Cancer Res,1999,59:2511-2515.
4Myers R B,Kudlow J E,Grizzle W E.Expression of transforming growth factor-alpha,epidermal growth factor and the epidermal growth factor recepor in adenocarcinoma of the prostate and benign prostatic hyperplasia.Mod Pathol,1993,6:733-737.
5Scott W W,Boyd H Z.Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of the prostate:a retrospective study based upon 25 years of experience.J Urol,1969,101:86-92.
6Kish J A.Neoadjuvant androgen ablation in localized carcinoma of the prostate.Cancer-controrl,2001,8:155-162.
7Stone N N,Stock R G,Unger P.Effects of Neoadjuvant normonal therapy on prostate biopsy results after 125I and 103Pd seed implantation.Mol Urol,2000,4:163-168.
2Holm HH,Stroyer I,Hansen H. Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy[J].Brit J Rad,1981,(664):665-670.
3Merrick GS,Butler WM,Lief JH. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation[J].{H}Techniques in Urology,2001,(03):233-240.
4Iannuzzi CM,Stock RG,Stone NN. PSA kinetics following Ⅱ-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer[J].Radiat OncoI Investig,1999,(01):30-35.
5Grimm PD,Blasko JC,Sylvester JE. 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy[J].{H}International Journal of Radiation Oncology Biology Physics,2001,(01):31-40.
8Hashine K, Kusuhara Y, Miura N, et aL A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer. Jpn J Clin Oncol 2008;38(7):480-485.
9Kranke P,Bennett M, Roeckl-Wiedmann I, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004;(2): CD004123.
